Sepsis update: fluids and steroids
Today's Hospitalist,
WHILE THE NEWS may have been buried a bit during the pandemic, the Surviving Sepsis Campaign issued revised guidelines in 2021…
WHILE THE NEWS may have been buried a bit during the pandemic, the Surviving Sepsis Campaign issued revised guidelines in 2021…
静脉液体复苏是脓毒性休克和脓毒症所致低血压患者的常用初始治疗措施。通过增加脓毒症血管扩张致血管内容量相对不足或功能性减少,从而改善大血管灌注(每搏输出量和心排血量)和微血管灌注(例如毛细血管血流)。但是,静脉液体复苏可导致稀释性凝血功能障碍、液体超负荷以及肺…
脓毒症休克的患者中,相较于非限制性补液策略,本试验所使用的限制性补液策略未显著降低(或增高)第90天全因死亡率。 本文由“围术期医学论坛"授权转载 脓毒症的特点包括全身大循环的改变,比如血容量的相对不足、血管张力和心肌收缩力减弱等,也包括微循环的改变,以及细…
1. Early use of vasopressors combined with a conservative fluid resuscitation did not result in a mortality benefit over a…